Gordian Capital (Singapore)’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,800
Closed -$259K 184
2024
Q4
$259K Buy
+1,800
New +$258K 0.13% 71
2024
Q3
Sell
-840
Closed -$106K 205
2024
Q2
$106K Buy
+840
New +$132K 0.06% 92

Other funds holding RGEN

Gordian Capital (Singapore)'s RGEN Position: Q1 2025 in Review

Gordian Capital (Singapore) sold out of Repligen (RGEN) in Q1 2025, closing a stake of 1,800 shares — an estimated $259K sold.

Gordian Capital (Singapore) first reported a position in RGEN in Q2 2024 and held it in 2 quarters. The position peaked at $259K in Q4 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • Gordian Capital (Singapore) reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
  • Gordian Capital (Singapore) sold 1,800 Repligen shares in Q1 2025, an estimated $259K.
  • Gordian Capital (Singapore) first reported a position in Repligen in Q2 2024 and held it in 2 quarters.
  • Gordian Capital (Singapore)'s Repligen position peaked at $259K in Q4 2024.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on Gordian Capital (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.